搜尋結果
2021年10月12日 · Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of
This medication is a treatment indicated as an adjunct to diet, exercise, and lifestyle changes such as weight loss to improve glycemic (blood sugar) control in adults with type 2 diabetes. Many patients with type 2 diabetes will eventually need to take insulin by injection. Metformin does not cause weight gain.
2023年9月26日 · Xigduo XR (dapagliflozin and metformin HCl) is a combination of two oral antihyperglycemic medications used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.
2023年11月20日 · Synjardy (empagliflozin and metformin hydrochloride) is a combination of a sodium-glucose co-transporter 2 (SGLT2) inhibitor and a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in ...
Empagliflozin-Metformin is a prescription medication used to treat the symptoms of Type 2 Diabetes Mellitus . Empagliflozin-Metformin is available under the following different brand names: Synjardy, Synjardy XR. What Are Dosages of Empagliflozin-Metformin? Adult dosage. Tablet, Immediate-Release. 5mg/500mg. 5mg/1000mg. 12.5mg/500mg. 12.5mg/1000mg.
2024年5月20日 · Xolremdi (mavorixafor) is a CXC chemokine receptor 4 antagonist indicated in patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) to increase the number of circulating mature neutrophils and lymphocytes.
2023年9月28日 · Jardiance (empagliflozin) is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2) used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Jardiance is also indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular ...